ENDUR-ACIN ER 750 mg 60 Tablets

ENDUR-ACIN Extended Release Niacin 750mg — Clinically Studied Wax Matrix Niacin for Cholesterol and Heart Health

ENDUR-ACIN ER from Endurance Products Company delivers 750mg of nicotinic acid (true niacin) in a proprietary SmartMatrix™ vegetable wax matrix that controls the release of niacin over 4–8 hours — dramatically slowing absorption and substantially reducing the prostaglandin-mediated skin flushing that is the primary tolerability barrier with immediate-release niacin. ENDUR-ACIN is backed by a portfolio of clinical research confirming its ability to help maintain blood lipid and cholesterol levels within the normal range at well-tolerated doses.

It is critical to understand that ENDUR-ACIN contains nicotinic acid — true niacin with documented cardiovascular and lipid effects — not niacinamide (nicotinamide) or inositol hexanicotinate, the 'flush-free' niacin forms that do not produce flushing because they do not convert efficiently to free nicotinic acid in the bloodstream and consequently have not been clinically shown to produce the lipid or cardiovascular benefits of true niacin. ENDUR-ACIN's wax matrix achieves the practical benefit of reduced flushing while maintaining the pharmacological profile of true nicotinic acid, making it the preferred form among clinicians who want niacin's genuine cardiovascular benefits with improved tolerability. Endurance Products has manufactured ENDUR-ACIN in Oregon since 1978, making it one of the longest-standing sustained-release niacin products in the supplement industry.

• Nicotinic acid 750mg per tablet — true niacin with clinically validated cardiovascular activity
• SmartMatrix™ vegetable wax matrix — 4–8 hour controlled release, reduced flushing
• Clinically studied — portfolio of research supporting cholesterol and lipid balance
• 60 tablets per bottle; vegan, gluten-free, no sugar/salt/preservatives

Take 1 tablet daily with food. Do not exceed 1 tablet daily without consulting a physician. Not for use with liver disease, gout, active peptic ulcer, or unstable angina without physician supervision.